AktienSensor - Latest Stock Market News, Financial Analysis & Investment Insights

Aktien Sensor

Gecina SA: Shareholder Stability, €17.4 B Portfolio, and Bold ESG Push 2026

Gecina SA: Shareholder Stability, €17.4 B Portfolio, and Bold ESG Push 2026

Explore Gecina’s 2026 filing—shareholder shifts, €17.4bn portfolio, ESG goals, and how Paris‑centric REITs navigate post‑pandemic office demand.

03/11/2026, 16:12

4 minutes to read

Top News

Reckitt Invests $120 M to Build U.S. Innovation Hub for Advanced Germ‑Protection

Reckitt Invests $120 M to Build U.S. Innovation Hub for Advanced Germ‑Protection

29/10/2026, 18:32

Sonova Holding AG Shares Dip Amid Market Softness, Yet Strong Hearing‑Aid Fundamentals Hold

Sonova Holding AG Shares Dip Amid Market Softness, Yet Strong Hearing‑Aid Fundamentals Hold

30/10/2026, 05:01

Glencore Buys Back Shares, Boosts Voting Rights & Revises Executive Pay for 2026

Glencore Buys Back Shares, Boosts Voting Rights & Revises Executive Pay for 2026

03/11/2026, 09:05

SS&C’s New EIGA ETF: Active Income Strategy Aiming for 5%+ Yields on ASX

SS&C’s New EIGA ETF: Active Income Strategy Aiming for 5%+ Yields on ASX

02/11/2026, 15:39

Market Overview

Top Sector News (Pharmaceuticals, Biotechnology & Life Sciences)

El Lilly Boosts 2026 Forecast: Weight‑Loss & Diabetes Drugs Outperform Expectations

El Lilly Boosts 2026 Forecast: Weight‑Loss & Diabetes Drugs Outperform Expectations

Dr. Sarah Winters

30/10/2026, 12:10

Regeneron Surges 13% on 5‑Billion‑Dollar Q3 Revenue & New Sanofi Deal

Regeneron Surges 13% on 5‑Billion‑Dollar Q3 Revenue & New Sanofi Deal

01/11/2026, 23:05

Pfizer’s Market Strategy: Navigating Patent Cliffs, M&A and Value‑Based Growth

Pfizer’s Market Strategy: Navigating Patent Cliffs, M&A and Value‑Based Growth

03/11/2026, 09:36

Sanofi Q3: 12% Revenue Surge, Dupixent Growth, and $1–$2B M&A Push

Sanofi Q3: 12% Revenue Surge, Dupixent Growth, and $1–$2B M&A Push

31/10/2026, 17:29

All News